S100 Relationship of cardiac biomarkers in COPD at stable state and exacerbation
Pauline R.M. Dobson(University of Sheffield), REK Russell(King's College London), Steven P. Cass(National Institute for Health Research), Jillian G. Baker(Nottingham University Hospitals NHS Trust), Wollaeger Ee(King's College London), M Bafadhel(King's College London), Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom))
Cited by 0
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434